This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes.
Lymphoma includes:
Series Description:
Emerging Cancer Therapeutics is an invited review publication providing a thorough analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence; current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the speciality, as well as on quality and outcomes analysis. Published three times a year, Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and haematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging.
"Sinopsis" puede pertenecer a otra edición de este libro.
Arnab Chakravarti, MD, Chair and Professor, Department of Radiation Oncology Max Morehouse Chair of Cancer Research, Co-Director, Brain Tumour Program, Arthur G. James Comprehensive Cancer Centre and Richard L. Solove Research Institute, The Ohio State University Medical School
Martin Fuss, MD, Professor and Vice Chair, Director Program in Image-guided Radiation Therapy, Department of Radiation Medicine, Oregon Health & Science University
Charles R. Thomas, MD, Professor and Chairman, Department of Radiation Medicine, Oregon Health and Science University
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: suffolkbooks, Center moriches, NY, Estados Unidos de America
hardcover. Condición: Very Good. Fast Shipping - Safe and Secure 7 days a week! Nº de ref. del artículo: 3TWDDA003NHW
Cantidad disponible: 3 disponibles
Librería: BOOKWEST, Phoenix, AZ, Estados Unidos de America
Hardcover. Condición: New. 1st Edition. SHRINK-WRAPPED: US SELLER SHIPS FROM USA. Nº de ref. del artículo: ORD7-S0-HC-1936287781-2P3-B6-MC-2012
Cantidad disponible: 1 disponibles
Librería: Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Reino Unido
Condición: As New. Nº de ref. del artículo: 096487-1
Cantidad disponible: 1 disponibles
Librería: Basi6 International, Irving, TX, Estados Unidos de America
Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Nº de ref. del artículo: ABEOCT25-230369
Cantidad disponible: 8 disponibles
Librería: Romtrade Corp., STERLING HEIGHTS, MI, Estados Unidos de America
Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Nº de ref. del artículo: ABBB-51700
Cantidad disponible: 5 disponibles
Librería: Books Puddle, Woodside, NY, Estados Unidos de America
Condición: New. pp. 208. Nº de ref. del artículo: 2642980168
Cantidad disponible: 4 disponibles
Librería: Majestic Books, Hounslow, Reino Unido
Condición: New. pp. 208. Nº de ref. del artículo: 49835159
Cantidad disponible: 4 disponibles
Librería: Revaluation Books, Exeter, Reino Unido
Hardcover. Condición: Brand New. 1st edition. 144 pages. 10.00x7.25x0.50 inches. In Stock. Nº de ref. del artículo: zk1936287781
Cantidad disponible: 1 disponibles
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Hardcover. Condición: new. Hardcover. This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes. Lymphoma includes: Details the most current management across the spectrum of lymphoma subtypes Expert contributors from across the US and Canada Multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical research with near-term potential in clinical management Series Description: Emerging Cancer Therapeutics is an invited review publication providing a thorough analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence; current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the speciality, as well as on quality and outcomes analysis. Published three times a year, Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and haematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging. This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lymphoma subtypes. It includes details the most current management across the spectrum of lymphoma subtypes; expert contributors from across the US and Canada; and multidisciplinary coverage and emphasis on emerging therapeutic options, cutting edge developments and clinical. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9781936287789
Cantidad disponible: 1 disponibles
Librería: UK BOOKS STORE, London, LONDO, Reino Unido
Condición: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability. Nº de ref. del artículo: CBS 9781936287789
Cantidad disponible: Más de 20 disponibles